Latest Ventricular assist device Stories
PLEASANTON, Calif., May 6, 2011 /PRNewswire/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the Bank of America Merrill Lynch 2011 Health Care Conference on Wednesday, May 11. David V. Smith, executive vice president and chief financial officer, will provide an update on the company, beginning at 8:40 a.m., Pacific Daylight Time (11:40 a.m.,...
BALTIMORE, May 6, 2011 /PRNewswire/ -- A new device designed to assist blood circulation and support blood pressure in high-risk patients undergoing percutaneous coronary intervention (PCI) has shown improved outcomes compared to the standard treatment with an intraaortic balloon pump. Results of the PROTECT II study were presented as a Late-Breaking Clinical Trial today at the SCAI 2011 Scientific Sessions in Baltimore. These devices decrease the heart's workload and increase blood...
FRAMINGHAM, Mass., and SYDNEY, May 6, 2011 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to make an investor presentation at the Bank of America Merrill Lynch Health Care Conference at 10:40 a.m. Pacific Time (1:40 p.m. ET) on Tuesday, May 10, 2011. The conference...
PLEASANTON, Calif., May 3, 2011 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today commented on an article published in the Journal of the American College of Cardiology (JACC) examining outcomes from a bridge-to-transplantation (BTT) post-approval study featuring the company's HeartMate II® LVAS (Left Ventricular Assist System). The article's lead authors include...
A series of new guidelines for cardiac specialists has been developed to determine when heart failure patients should receive a mechanical heart-pumping device."The new guidelines will likely affect who is referred for a mechanical circulatory support device, and how early in the process a physician would consider implanting a left ventricular assist device," says Jeffrey A. Morgan, M.D., associate director of Mechanical Circulatory Support at Henry Ford Hospital. "These...
Non-cardiac surgery can be performed safely in patients with a heart device typically implanted into patients waiting for a transplant, according to a study at Henry Ford Hospital in Detroit.The left ventricular assist device (LVAD) is a mechanical pump implanted in the chest to help a weakened heart pump blood.The devices are increasingly used in the United States, where heart failure affects five million people, but there are less than 3,000 donor organs available annually worldwide. Last...
SAN DIEGO, April 14, 2011 /PRNewswire/ -- Promising new devices for mechanical circulatory support of children with heart defects or heart failure, and related research, will be revealed this week at the International Society for Heart and Lung Transplantation (ISHLT) 31st Annual Meeting and Scientific Sessions. An update from the Pumps for Kids, Infants and Neonates (PumpKIN) Program will be presented during the Meeting in San Diego. PumpKIN is supported by the National Heart, Lung, and...
PLEASANTON, Calif., April 13, 2011 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the first quarter of fiscal 2011 on Tuesday, May 3. The company will hold a conference call to discuss its financial results and operating activities open to all interested parties at 1:30 p.m., Pacific Daylight Time (4:30 p.m.,...
FRAMINGHAM, Mass. and SYDNEY, April 12, 2011 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the HeartWare® Ventricular Assist System will be the subject of presentations at The International Society of Heart and Lung Transplantation (ISHLT) 31st Annual Meeting and Scientific Sessions, April...
Study reviews staffing environment, needs at heart failure programs nationwideThe American College of Cardiology Foundation (ACCF), American Heart Association (AHA) and the Heart Failure Society of America (HFSA) today released results of a recently conducted survey to determine the current staffing environment of heart failure (HF) clinics and offices focused on heart transplants.One in eight deaths in the United States is a result of heart failure and the HF patient population is growing,...
Latest Ventricular assist device Reference Libraries
The artificial heart, a mechanical heart replacement, is typically used in order to bridge the time to heart transplant or to replace the heart in case a transplant is impossible. Often ventricular assist devices are confused with mechanical hearts because the assist the heart through pumps. They are also different from a cardiopulmonary bypass machine which is an external device used to provide the function of the heart and lungs. CPBs are usually only used for a few hours at a time,...
